Summary:
A PHASE 1 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED MODIFIED RNA VACCINE CANDIDATES AGAINST COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS
Qualified Participants Must:
Must be 18 to 64 years old
Have not received a Flu vaccine in the last 6 months
Have only received Pfizer COVID vaccinations
Have received 2 Pfizer COVID vaccinations and 1 Pfizer COVID booster
Have received last Booster 150 to 365 days ago.